Migraine with Aura
A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Drugs by status
Approved for this indication (4)
Phase 4 trials (11)
Phase 3 trials (10)
Phase 2 trials (13)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (16)
- Takeda
- Ariston Pharmaceuticals, Inc.
- Minster Research Ltd
- NeurAxon Inc.
- Nektar Therapeutics
- Solvay
- Canisius-Wilhelmina Hospital
- University of London
- University of Washington
- University of Connecticut
- University of Copenhagen
- University of Montreal
- Dr. Reddy's Laboratories
- University of Nice Sophia Antipolis
- Yeshiva University
- Corona Doctors Medical Clinics, Inc.
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (4)